Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemgene Holding is a biotechnology company specializing in the development and manufacture of high-quality raw materials for molecular diagnostics and life science research. The company provides a wide range of products, including modified nucleotides, phosphoramidites, enzymes, and customized synthesis services. Headquartered in Suzhou, China, Chemgene serves global pharmaceutical and diagnostic companies by offering critical components for DNA/RNA synthesis and sequencing. Their expertise lies in chemical synthesis and protein engineering, enabling the production of high-purity reagents for in vitro diagnostic (IVD) applications. The company operates large-scale manufacturing facilities to support the growing demand for genomic and proteomic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemgene Holding.